AMREP CORP (AXR) Fundamental Analysis & Valuation

NYSE:AXR • US0321591051

Current stock price

27.27 USD
0 (0%)
Last:

This AXR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. AXR Profitability Analysis

1.1 Basic Checks

  • In the past year AXR was profitable.
  • In the past year AXR had a positive cash flow from operations.
  • In the past 5 years AXR has always been profitable.
  • Each year in the past 5 years AXR had a positive operating cash flow.
AXR Yearly Net Income VS EBIT VS OCF VS FCFAXR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M

1.2 Ratios

  • AXR has a Return On Assets of 8.98%. This is amongst the best in the industry. AXR outperforms 96.77% of its industry peers.
  • AXR has a Return On Equity of 9.28%. This is amongst the best in the industry. AXR outperforms 83.87% of its industry peers.
  • AXR has a Return On Invested Capital of 8.52%. This is amongst the best in the industry. AXR outperforms 96.77% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for AXR is above the industry average of 5.48%.
  • The last Return On Invested Capital (8.52%) for AXR is above the 3 year average (7.98%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROIC 8.52%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
AXR Yearly ROA, ROE, ROICAXR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • The Profit Margin of AXR (24.40%) is better than 87.10% of its industry peers.
  • In the last couple of years the Profit Margin of AXR has declined.
  • Looking at the Operating Margin, with a value of 26.06%, AXR belongs to the top of the industry, outperforming 91.94% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AXR has declined.
  • Looking at the Gross Margin, with a value of 42.44%, AXR is in the better half of the industry, outperforming 70.97% of the companies in the same industry.
  • In the last couple of years the Gross Margin of AXR has grown nicely.
Industry RankSector Rank
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
AXR Yearly Profit, Operating, Gross MarginsAXR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. AXR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXR is destroying value.
  • The number of shares outstanding for AXR has been increased compared to 1 year ago.
  • Compared to 5 years ago, AXR has less shares outstanding
  • Compared to 1 year ago, AXR has an improved debt to assets ratio.
AXR Yearly Shares OutstandingAXR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M
AXR Yearly Total Debt VS Total AssetsAXR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • AXR has an Altman-Z score of 21.67. This indicates that AXR is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of AXR (21.67) is better than 100.00% of its industry peers.
  • The Debt to FCF ratio of AXR is 0.00, which is an excellent value as it means it would take AXR, only 0.00 years of fcf income to pay off all of its debts.
  • AXR has a better Debt to FCF ratio (0.00) than 90.32% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that AXR is not too dependend on debt financing.
  • AXR's Debt to Equity ratio of 0.00 is amongst the best of the industry. AXR outperforms 88.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 21.67
ROIC/WACC0.96
WACC8.9%
AXR Yearly LT Debt VS Equity VS FCFAXR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.3 Liquidity

  • A Current Ratio of 25.70 indicates that AXR has no problem at all paying its short term obligations.
  • AXR's Current ratio of 25.70 is amongst the best of the industry. AXR outperforms 100.00% of its industry peers.
  • AXR has a Quick Ratio of 11.00. This indicates that AXR is financially healthy and has no problem in meeting its short term obligations.
  • AXR has a Quick ratio of 11.00. This is amongst the best in the industry. AXR outperforms 96.77% of its industry peers.
Industry RankSector Rank
Current Ratio 25.7
Quick Ratio 11
AXR Yearly Current Assets VS Current LiabilitesAXR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. AXR Growth Analysis

3.1 Past

  • The earnings per share for AXR have decreased by -0.33% in the last year.
  • The Earnings Per Share has been growing slightly by 2.33% on average over the past years.
  • Looking at the last year, AXR shows a decrease in Revenue. The Revenue has decreased by -8.70% in the last year.
  • Measured over the past years, AXR shows a very strong growth in Revenue. The Revenue has been growing by 21.46% on average per year.
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%

3.2 Future

  • AXR is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.71% yearly.
  • Based on estimates for the next years, AXR will show a quite strong growth in Revenue. The Revenue will grow by 11.91% on average per year.
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue Next Year10.12%
Revenue Next 2Y1.33%
Revenue Next 3Y1.81%
Revenue Next 5Y11.91%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXR Yearly Revenue VS EstimatesAXR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20M 40M 60M
AXR Yearly EPS VS EstimatesAXR Yearly EPS VS EstimatesYearly EPS VS Estimates 2026 2027 2028 2029 0.5 1 1.5 2 2.5

More info and screens

Find the best growth stocksShow best growing peers

7

4. AXR Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.32, the valuation of AXR can be described as reasonable.
  • Based on the Price/Earnings ratio, AXR is valued cheaper than 87.10% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.95, AXR is valued rather cheaply.
  • A Price/Forward Earnings ratio of 12.92 indicates a correct valuation of AXR.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of AXR indicates a rather cheap valuation: AXR is cheaper than 91.94% of the companies listed in the same industry.
  • AXR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.68.
Industry RankSector Rank
PE 11.32
Fwd PE 12.92
AXR Price Earnings VS Forward Price EarningsAXR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • AXR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AXR is cheaper than 98.39% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, AXR is valued cheaply inside the industry as 88.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.05
EV/EBITDA 6.72
AXR Per share dataAXR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The excellent profitability rating of AXR may justify a higher PE ratio.
  • AXR's earnings are expected to decrease with -2.55% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AXR Dividend Analysis

5.1 Amount

  • No dividends for AXR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AXR Fundamentals: All Metrics, Ratios and Statistics

AMREP CORP

NYSE:AXR (4/20/2026, 8:04:00 PM)

27.27

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)03-12
Earnings (Next)07-23
Inst Owners44.99%
Inst Owner Change0.03%
Ins Owners45.81%
Ins Owner Change2.6%
Market Cap144.80M
Revenue(TTM)53.00M
Net Income(TTM)12.93M
Analysts80
Price Target30.6 (12.21%)
Short Float %0.89%
Short Ratio2.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-24.87%
Min EPS beat(2)-50.49%
Max EPS beat(2)0.75%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-17.5%
Min Revenue beat(2)-37.84%
Max Revenue beat(2)2.84%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)30.43%
PT rev (3m)30.43%
EPS NQ rev (1m)-23.21%
EPS NQ rev (3m)-23.21%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.45%
Revenue NQ rev (1m)-11.9%
Revenue NQ rev (3m)-11.9%
Revenue NY rev (1m)-2.06%
Revenue NY rev (3m)-2.06%
Valuation
Industry RankSector Rank
PE 11.32
Fwd PE 12.92
P/S 2.73
P/FCF 11.05
P/OCF 10.61
P/B 1.04
P/tB 1.04
EV/EBITDA 6.72
EPS(TTM)2.41
EY8.84%
EPS(NY)2.11
Fwd EY7.74%
FCF(TTM)2.47
FCFY9.05%
OCF(TTM)2.57
OCFY9.42%
SpS9.98
BVpS26.25
TBVpS26.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number37.727 (38.35%)
Profitability
Industry RankSector Rank
ROA 8.98%
ROE 9.28%
ROCE 9.91%
ROIC 8.52%
ROICexc 13.29%
ROICexgc 13.34%
OM 26.06%
PM (TTM) 24.4%
GM 42.44%
FCFM 24.74%
ROA(3y)11.25%
ROA(5y)11.62%
ROE(3y)11.7%
ROE(5y)12.51%
ROIC(3y)7.98%
ROIC(5y)10.76%
ROICexc(3y)10.52%
ROICexc(5y)13.87%
ROICexgc(3y)10.56%
ROICexgc(5y)13.9%
ROCE(3y)9.27%
ROCE(5y)12.5%
ROICexgc growth 3Y-24.11%
ROICexgc growth 5YN/A
ROICexc growth 3Y-24.15%
ROICexc growth 5YN/A
OM growth 3Y-12.34%
OM growth 5YN/A
PM growth 3Y-1.77%
PM growth 5YN/A
GM growth 3Y-4.88%
GM growth 5Y19.57%
F-Score5
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 179.26%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 96.71%
Profit Quality 101.38%
Current Ratio 25.7
Quick Ratio 11
Altman-Z 21.67
F-Score5
WACC8.9%
ROIC/WACC0.96
Cap/Depr(3y)283.02%
Cap/Depr(5y)282.35%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.91%
Profit Quality(3y)86%
Profit Quality(5y)103.5%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.33%
EPS 3Y2.33%
EPS 5YN/A
EPS Q2Q%338.11%
EPS Next Y-4.9%
EPS Next 2Y-5.59%
EPS Next 3Y-2.55%
EPS Next 5Y2.71%
Revenue 1Y (TTM)-8.7%
Revenue growth 3Y-5.51%
Revenue growth 5Y21.46%
Sales Q2Q%93.79%
Revenue Next Year10.12%
Revenue Next 2Y1.33%
Revenue Next 3Y1.81%
Revenue Next 5Y11.91%
EBIT growth 1Y4.28%
EBIT growth 3Y-17.16%
EBIT growth 5YN/A
EBIT Next Year19.88%
EBIT Next 3Y1.05%
EBIT Next 5Y6.19%
FCF growth 1Y20.66%
FCF growth 3Y-12.03%
FCF growth 5Y66.27%
OCF growth 1Y22.02%
OCF growth 3Y-12.86%
OCF growth 5Y67.79%

AMREP CORP / AXR Fundamental Analysis FAQ

What is the fundamental rating for AXR stock?

ChartMill assigns a fundamental rating of 7 / 10 to AXR.


What is the valuation status for AXR stock?

ChartMill assigns a valuation rating of 7 / 10 to AMREP CORP (AXR). This can be considered as Undervalued.


What is the profitability of AXR stock?

AMREP CORP (AXR) has a profitability rating of 8 / 10.


What are the PE and PB ratios of AMREP CORP (AXR) stock?

The Price/Earnings (PE) ratio for AMREP CORP (AXR) is 11.32 and the Price/Book (PB) ratio is 1.04.


How financially healthy is AMREP CORP?

The financial health rating of AMREP CORP (AXR) is 9 / 10.